Tag: Patent
Apples and Oranges: Comparing Assertions of SEPs and Differentiating Patents from...
This article is part of a Chronicle. See more from this Chronicle
Jay Jurata, Adya Baker, Mar 31, 2015
Intellectual property and antitrust laws share a...
The Application of China’s Anti-Monopoly Law to Essential Patent Licensing: The...
This article is part of a Chronicle. See more from this Chronicle
James Rill, James Kress, Mar 31, 2015
With last month’s widely anticipated conclusion of...
Updating a Patent Policy: The IEEE Experience
This article is part of a Chronicle. See more from this Chronicle
Michael Lindsay, Konstantinos Konstantinos, Mar 31, 2015
The pages of this two-part issue of...
Original Sin
This article is part of a Chronicle. See more from this Chronicle
John Harkrider, Mar 31, 2015
While SEPs could be a potential predator in the...
Standards, Royalty Stacking, and Collective Action
This article is part of a Chronicle. See more from this Chronicle
Jorge Contreras, Mar 31, 2015
This article summarizes economic and legal theories regarding royalty...
Intellectual Ventures v. Capital One: Can Antitrust Law and Economics Get...
This article is part of a Chronicle. See more from this Chronicle
Michelle Miller, Janusz Ordover, Jan 29, 2015
Patent trolls are currently under intense scrutiny...
Angels Rush in Where Fools Fear to Tread: State Enforcement Against...
This article is part of a Chronicle. See more from this Chronicle
Jay Himes, Matthew Perez, Jan 14, 2014
Nobody likes trolls-those mythical creatures, "considered dangerous...
Canadian Perspectives on Competition Law and Reverse Payments Following FTC v....
David Rosner, Navin Joneja, Joshua Krane, Sep 30, 2013
The Canadian Competition Bureau, pharmaceutical companies operating in Canada, and Canadian lawyers have been following the...
Reverse Payment Settlements: Presumptively Bad or Usually Acceptable?
Kyle Musgrove, Richard Ripley, Jun 27, 2012
In April 2012, the Federal Trade Commission ("FTC") suffered yet another rebuke of what FTC Chair Jon Leibowitz...
Comment on the EC’s Pharmaceutical Dawn Raids
This article is part of a Chronicle. See more from this Chronicle
Susan Creighton, Scott Russell, Feb 14, 2008
The pharmaceutical industry remains under close examination...
